The Comprehensive Sickle Cell Center has led multiple clinical research studies, many of which have already been translated into improved patient care for this population. The principal investigators in the Center are in constant pursuit of knowledge that will provide improved therapies and ultimately cure this genetic disease.
In addition to ongoing clinical trials, the Center is also exploring the issue of care transition—the process of preparing to leave the pediatric environment to begin receiving treatment from doctors who are trained to care for adults. At UAB, preparation for transition of care begins at 12 years of age with a formalized transition program based on a nationally-recommended best practices. UAB recently joined a PCORI funded transition project known as ST3P UP to incorporate peer mentoring into the transition process. Ultimate transfer of care to an adult care provider occurs around 18 years of age in collaboration with the UAB adult clinic and community based organization partners.
Sickle Cell Disease Network of Central Alabama Clinical Research Sites
Adult Sickle Cell Clinic at UAB Russell Clinic
The Adult Sickle Cell Clinic is located on the first floor of the UAB Russell Clinic. It is open Monday-Friday from 8 a.m-5 p.m. The Clinic offers infusion therapy for pain management as well as blood transfusions, exchanges and phlebotomy. Dr. Kanter leads this clinic.
Children’s of Alabama/UAB Pediatric Hematology Clinic
The Hematology Outpatient Clinic serves pediatric sickle cell patients receiving disease-modifying therapies, participating in clinical trials, or with acute complications five days a week. Dr. Lebensburger leads this clinic.
Montgomery Site at UAB Montgomery
Held twice monthly, is led by Dr. Thomas Howard.
Opelika Site at East Alabama Medical Center Clinic
Held every other month, site is led by Dr. Lee Hilliard.
Tuscaloosa Site at University of Alabama Health Sciences Campus
Held quarterly, the site is led by Brandi Pernell, DNP, with physician support from Drs. Howard, Lebensburger and Hilliard.